117ACTIVITIES
4ORGS REPRESENTED
5BILLS
Revolving door — covered positions
Federal positions Kimberlee held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
FDA. Dep. Commissioner
8/23-1/25. Assoc. Commissioner Leg. Affairs
2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA
Organizations represented
4Orgs whose LD-2 filings list Kimberlee as an active lobbyist, sorted by activity volume.
Bills they file on
5Topics in Filings
16Policy topics Kimberlee files on across all their LD-2 activities.
Surrounding improvements to clinical research capabilities and modernization×18
Community Health Centers Funding×12
PACE Programs×12
Surrounding Medicare Advantage Policy, including the annual Rate Notice×9
Surrounding Medicare Advantage risk adjustment, including home risk assessments×9
Pharmacy issues×6
Surrounding pharmacy benefit managers, and coverage of biosimilars×6
Medicare payment issues, appointment to Medicare Payment Advisory Commission×6
Medicare Advantage×6
Medicaid Dual Eligibles, and Medicare reimbursement and enrollment×6
Surrounding US Pharmaceutical supply chain×6
Surrounding the generic drug and biosimilar user free agreements×6
Show all 16 topics (+4 more) ▾
Surrounding the regulation of complex generic drugs×6
Surrounding Medicare reimbursement of generic drugs and biosimilars×6
Skinny Labels×1
Big Savings Act×1
Issue mix
LDA general-issue codes weighted by activity count.
Medicare/Medicaid49
Health Issues33
Defense13
Trade (domestic/foreign)9
Food Industry (safety, labeling, etc.)6
Pharmacy6
Copyright/Patent/Trademark1